Live feed
Filing
SC 13D/A
SC 13D/A0001104659-23-024270·Foresite Capital Fund IV, L.P.
Schedule 13D ownership disclosure
KINNATE BIOPHARMA INC
Security class unavailable · CUSIP: 49705R105
Event date: 2023-02-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 9,671,643
- Percent of class
- 20.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-23-024270
- Form type
- SC 13D/A
- Filer
- Foresite Capital Fund IV, L.P.
- CIK
- CIK 1704131
- Filed
- Feb 22, 2023
- Reporting period
- Feb 17, 2023
- Description
- Schedule 13D beneficial ownership